Ryan Specialty (NYSE:RYAN) Given New $50.00 Price Target at Morgan Stanley

Ryan Specialty (NYSE:RYAN) had its price objective reduced by analysts at Morgan Stanley from $55.00 to $50.00 in a report released on Monday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 48.36% from the company’s previous close.

A number of other brokerages have also recently commented on RYAN. BMO Capital Markets cut shares of Ryan Specialty from an “outperform” rating to a “market perform” rating and cut their target price for the company from $66.00 to $43.00 in a report on Wednesday, February 25th. Zacks Research downgraded Ryan Specialty from a “hold” rating to a “strong sell” rating in a research note on Tuesday, February 24th. Cantor Fitzgerald dropped their price objective on shares of Ryan Specialty from $52.00 to $45.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 17th. Mizuho dropped their price target on shares of Ryan Specialty from $53.00 to $44.00 and set a “neutral” rating on the stock in a research note on Friday, February 27th. Finally, The Goldman Sachs Group set a $61.00 price objective on Ryan Specialty in a report on Wednesday, January 7th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Ryan Specialty currently has an average rating of “Hold” and a consensus target price of $54.19.

Ryan Specialty Stock Up 0.6%

Shares of Ryan Specialty stock traded up $0.19 during trading hours on Monday, reaching $33.70. 171,333 shares of the company were exchanged, compared to its average volume of 2,077,682. Ryan Specialty has a 1 year low of $31.50 and a 1 year high of $75.26. The firm has a market cap of $8.90 billion, a PE ratio of 80.30, a PEG ratio of 0.88 and a beta of 0.71. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98. The stock’s fifty day moving average is $39.56 and its 200 day moving average is $49.01.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Thursday, February 12th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The firm had revenue of $751.21 million for the quarter, compared to analyst estimates of $777.43 million. Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The business’s revenue for the quarter was up 13.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.45 EPS. As a group, equities research analysts forecast that Ryan Specialty will post 2.29 earnings per share for the current year.

Insider Buying and Selling at Ryan Specialty

In related news, Director Patrick G. Ryan, Jr. bought 25,500 shares of the stock in a transaction dated Monday, February 23rd. The stock was acquired at an average price of $39.96 per share, for a total transaction of $1,018,980.00. Following the completion of the purchase, the director owned 428,295 shares in the company, valued at $17,114,668.20. This represents a 6.33% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 52.21% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Ryan Specialty

A number of large investors have recently bought and sold shares of RYAN. T. Rowe Price Investment Management Inc. boosted its position in Ryan Specialty by 79.9% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,552,002 shares of the company’s stock valued at $389,910,000 after purchasing an additional 3,353,926 shares during the period. Capital World Investors grew its stake in shares of Ryan Specialty by 0.3% in the 4th quarter. Capital World Investors now owns 6,640,638 shares of the company’s stock worth $342,856,000 after purchasing an additional 17,082 shares during the last quarter. Vulcan Value Partners LLC lifted its holdings in shares of Ryan Specialty by 631.7% during the fourth quarter. Vulcan Value Partners LLC now owns 4,621,079 shares of the company’s stock valued at $238,536,000 after purchasing an additional 3,989,502 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of Ryan Specialty by 21.1% during the third quarter. Principal Financial Group Inc. now owns 4,392,717 shares of the company’s stock valued at $247,576,000 after acquiring an additional 765,428 shares during the period. Finally, Montrusco Bolton Investments Inc. grew its position in Ryan Specialty by 9.3% during the 4th quarter. Montrusco Bolton Investments Inc. now owns 4,343,116 shares of the company’s stock worth $218,010,000 after purchasing an additional 368,247 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.